Publication | Open Access
A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study
130
Citations
43
References
2020
Year
This trial suggests that PE with albumin replacement could slow cognitive and functional decline in AD, although further studies are warranted.
| Year | Citations | |
|---|---|---|
Page 1
Page 1